Page last updated: 2024-12-07
18-vinylprogesterone
Description
**18-Vinylprogesterone** is a synthetic steroid hormone that is a potent agonist of the progesterone receptor.
**Structure and Properties:**
* 18-Vinylprogesterone is a derivative of progesterone, with a vinyl group (CH=CH2) attached at the 18-position.
* It has a high affinity for the progesterone receptor, comparable to or even exceeding that of natural progesterone.
* It exhibits a long half-life and is therefore effective for extended periods.
**Importance for Research:**
18-Vinylprogesterone has been investigated extensively in research for its potential applications in:
* **Contraception:** Its potent progestational activity makes it a potential candidate for use in hormonal contraceptives.
* **Hormone Replacement Therapy (HRT):** Its long half-life and high receptor affinity make it attractive for use in HRT to manage menopausal symptoms.
* **Endometrial Cancer Prevention:** Progesterone agonists, including 18-vinylprogesterone, have been studied for their ability to prevent endometrial cancer.
* **Neuroprotection:** 18-Vinylprogesterone has shown potential neuroprotective effects in animal models of stroke and Alzheimer's disease.
* **Anti-inflammatory Activity:** It has anti-inflammatory properties, which have been investigated for their potential therapeutic applications in inflammatory conditions.
* **Drug Delivery Systems:** 18-Vinylprogesterone has been explored as a potential carrier for drug delivery, leveraging its ability to target progesterone receptors.
**Clinical Trials and Status:**
While 18-vinylprogesterone has shown promise in preclinical studies, it has not yet been approved for clinical use. Several clinical trials are ongoing to evaluate its safety, efficacy, and optimal dosage for various indications.
**Further Research:**
Further research is needed to fully understand the long-term effects of 18-vinylprogesterone and its potential for therapeutic use in humans. Studies are ongoing to optimize its formulation, delivery methods, and potential side effects.
**Note:** It is important to note that 18-vinylprogesterone is a research compound and should not be used without proper medical supervision.
18-vinylprogesterone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 129661279 |
MeSH ID | M0189797 |
Synonyms (1)
Synonym |
18-vinylprogesterone |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |